UNSPSC 51342312: Entecavir hydrate

This classification denotes an antiviral agent with the molecular formula C12H15N5O3.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5968Y6H45M, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((1s,3r,4s)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)- monohydrate, but more generally known as entecavir hydrate, which bears US NIH Compound Identifier 170342. European Medicines Agency schedules entecavir hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21468.

Most nations, for tariff purposes, schedule entecavir hydrate under HS 29335995. SMILES: C=C1[C@H](C[C@@H]([C@H]1CO)O)N2CNC3C2NC([NH]C3=O)N.O.

UNSPSC 51342312 Entecavir hydrate is a Commodity code that nominally covers a specific antiviral pharmaceutical active ingredient, but recent state and local procurement activity shows a mismatch: the code has generated no relevant solicitations for entecavir itself. Instead, the recent opportunities tagged to this code span broader pharmaceutical and medical supply procurement — generic multi-source pharmaceuticals, over-the-counter products, naloxone, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription programs. State and local governments are buying medical and pharmaceutical products through cooperative purchasing vehicles, competitive sealed bidding, and request-for-information processes, but none of the recent opportunities explicitly target entecavir or closely related antiviral therapeutics. The issuing bodies include a state health and human services commission (Texas HHS Commission), a state-level cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon), a county public health department (Seminole County, Florida), and a municipal fire department (Tampa Fire Department).

Geographic activity spans Texas, Minnesota, Oregon, and Florida based on recent opportunities. The Minnesota Multistate Cooperative Purchasing Alliance RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026) represents the largest and most formally structured procurement, with requirements for cGMP certification, DSCSA compliance, and wholesaler relationships. The Texas HHS Commission issued a Request for Information in April 2026 to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. Seminole County, Florida solicited naloxone and drug deactivation systems (IFB, due July 26, 2023) in support of community health initiatives, and the City of Tampa issued a sealed-bid invitation for medical and first aid supplies for fire department rescue operations (due March 13, 2026), designated as a sheltered-market procurement for certified Small Local Business Enterprises with an estimated contract value of $700,000.00. The code shows insufficient activity in entecavir-specific procurement to support pursuit at the commodity level; business development professionals should monitor the broader pharmaceutical and medical-supply codes if capability exists in those categories.